Guided Therapeutics Inc  

(Public, OTCBB:GTHP)   Watch this stock  
Find more results for OTC:GTHP
+0.006 (1.28%)
Apr 23 - Close
OTCBB data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.46 - 0.47
52 week 0.40 - 0.98
Open 0.46
Vol / Avg. 26,300.00/62,819.00
Mkt cap 34.07M
P/E     -
Div/yield     -
EPS -0.16
Shares 71.72M
Beta 0.60
Inst. own 0%
Mar 24, 2014
Q4 2013 Guided Therapeutics Inc. Earnings Release (Estimated)

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -554.64% -611.96%
Operating margin -338.85% -560.31%
EBITD margin - -521.20%
Return on average assets -284.18% -212.39%
Return on average equity - -
Employees 34 -
CDP Score - -


Suite D, 5835 Peachtree Corner
United States - Map
+1-770-2428723 (Phone)
+1-770-2428639 (Fax)

Website links


Guided Therapeutics, Inc. is a medical technology company focused on developing medical devices. The Company�s primary focus is the development of its LuViva non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, especially esophageal. Its technology, including products in research and development, primarily relate to biophotonics technology for the non-invasive detection of cancers. LuViva is a non-invasive cervical cancer detection product, based on the Company's biophotonic technology. The device is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix.

Officers and directors

Michael C. James Chairman of the Board
Age: 55
Gene Cartwright Ph.D. Chief Executive Officer, Chief Scientific Officer, Director
Age: 59
Ronald W. Hart Ph.D. Independent Vice Chairman of the Board
Age: 71
Richard L. Fowler Senior Vice President - Engineering
Age: 57
John E. Imhoff M.D. Independent Director
Age: 64
Jonathan M. Niloff M.D. Independent Director
Age: 58
Linda M. Rosenstock M.D. Independent Director
Age: 62